Vierfach-Kombination beim nichtseminomatösen Hodentumor mit ungünstiger Prognose
- 1 January 1988
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Chemotherapy of disseminated germ cell tumorsCancer, 1987
- Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.Journal of Clinical Oncology, 1987
- Die Chemotherapie von HodentumorenPublished by Springer Nature ,1987
- High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1986
- Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group studyCancer, 1984
- Bleomycin-induzierte Lungeninfiltrate bei der Behandlung von HodenkarzinomenJournal of Molecular Medicine, 1984
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumorsCancer, 1983
- The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow supportPublished by Elsevier ,1981